By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Indian firm Ocimum Biosolutions today announced it has closed on an $8 million round, which it will use to enhance its Research as a Service platform.

The company, based in Hyderabad, said that investors came from multiple sources, including its founders and existing shareholders. It provides a wide array of services including GLP-compliant microarray services, genomic reference databases, life science laboratory management solutions, and research consumables.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.